Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ
Islam M. Miligy, Priya Mohan, Ahmed Gaber, et al.
Histopathology (2017) Vol. 71, Iss. 2, pp. 258-268
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Soizic Garaud, Laurence Buisseret, Cinzia Solinas, et al.
JCI Insight (2019) Vol. 4, Iss. 18
Open Access | Times Cited: 285
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer
Stephanie L. Goff, David N. Danforth
Clinical Breast Cancer (2020) Vol. 21, Iss. 1, pp. e63-e73
Open Access | Times Cited: 153
B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication
Gabriela Sarti Kinker, Glauco Akelinghton Freire Vitiello, Wallax Augusto Silva Ferreira, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 106
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
Joe Yeong, Jeffrey Chun Tatt Lim, Bernett Lee, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 126
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 118
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
Kylie L. Gorringe, Stephen B. Fox
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 105
The Role of Chronic Inflammation in the Development of Breast Cancer
David N. Danforth
Cancers (2021) Vol. 13, Iss. 15, pp. 3918-3918
Open Access | Times Cited: 96
New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
Meng Shen, Jian Wang, Xiubao Ren
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 84
The Role of Tumor-Infiltrating B Cells in Tumor Immunity
Fei Fei Guo, Jiu Wei Cui
Journal of Oncology (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 80
Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer
Soizic Garaud, Pawel Zayakin, Laurence Buisseret, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 77
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
Michael S. Toss, Islam M. Miligy, Abdubaqi Al-Kawaz, et al.
Modern Pathology (2018) Vol. 31, Iss. 8, pp. 1226-1236
Open Access | Times Cited: 66
The clinical significance of HER2 expression in DCIS
Ιωάννα Ακρίδα, Francesk Mulita
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 33
B Cells in Breast Cancer Pathology
Mengyuan Li, Ángela Quintana, Elena Alberts, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1517-1517
Open Access | Times Cited: 17
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
Elin Sjöberg, Magnus Frödin, John Lövrot, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 7, pp. 840-846
Open Access | Times Cited: 49
Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
Milim Kim, Yul Ri Chung, Hyun Jeong Kim, et al.
Breast Cancer Research (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 48
Immune microenvironment in different molecular subtypes of ductal breast carcinoma
Mona Sadeghalvad, Hamid‐Reza Mohammadi‐Motlagh, Nima Rezaei
Breast Cancer Research and Treatment (2020) Vol. 185, Iss. 2, pp. 261-279
Closed Access | Times Cited: 43
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis
You Qin, Peng Fei, Lisha Ai, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 39
The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
Mingwei Ma, Juan Sun, Zhen Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Michael S. Toss, Asima Abidi, Dorothea Lesche, et al.
British Journal of Cancer (2020) Vol. 122, Iss. 10, pp. 1496-1506
Open Access | Times Cited: 39
Prognostic role of immune infiltrates in breast ductal carcinoma in situ
Xiaoyang Chen, Joe Yeong, Aye Aye Thike, et al.
Breast Cancer Research and Treatment (2019) Vol. 177, Iss. 1, pp. 17-27
Closed Access | Times Cited: 36
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis
Alexandra Giatromanolaki, Anastasia G. Gkegka, Stamatia Pouliliou, et al.
Breast Cancer Research and Treatment (2022) Vol. 194, Iss. 1, pp. 13-23
Closed Access | Times Cited: 20
A prognostic and predictive computational pathology immune signature for ductal carcinoma in situ: retrospective results from a cohort within the UK/ANZ DCIS trial
Haojia Li, Arpit Aggarwal, Paula Toro, et al.
The Lancet Digital Health (2024) Vol. 6, Iss. 8, pp. e562-e569
Open Access | Times Cited: 4
B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
Nicole J. Toney, Lynn M. Opdenaker, Lisa Frerichs, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses
Helga Bergholtz, Jens Henrik Norum, Tonje G. Lien, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top